These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 12954840)

  • 1. Preoperative use of recombinant human erythropoietin before total joint arthroplasty.
    Bezwada HP; Nazarian DG; Henry DH; Booth RE
    J Bone Joint Surg Am; 2003 Sep; 85(9):1795-800. PubMed ID: 12954840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost minimization analysis of preoperative erythropoietin vs autologous and allogeneic blood donation in total joint arthroplasty.
    Green WS; Toy P; Bozic KJ
    J Arthroplasty; 2010 Jan; 25(1):93-6. PubMed ID: 19056224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of perioperative blood loss in total joint arthroplasty.
    Park JH; Rasouli MR; Mortazavi SM; Tokarski AT; Maltenfort MG; Parvizi J
    J Bone Joint Surg Am; 2013 Oct; 95(19):1777-83. PubMed ID: 24088970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative autologous donation for total joint arthroplasty. An analysis of risk factors for allogenic transfusion.
    Hatzidakis AM; Mendlick RM; McKillip T; Reddy RL; Garvin KL
    J Bone Joint Surg Am; 2000 Jan; 82(1):89-100. PubMed ID: 10653088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized study of preoperative autologous donation for hip replacement surgery.
    Billote DB; Glisson SN; Green D; Wixson RL
    J Bone Joint Surg Am; 2002 Aug; 84(8):1299-304. PubMed ID: 12177257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of Epoetin alfa in complex spine deformity surgery.
    Shapiro GS; Boachie-Adjei O; Dhawlikar SH; Maier LS
    Spine (Phila Pa 1976); 2002 Sep; 27(18):2067-71. PubMed ID: 12634571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction of preoperative autologous blood donation for primary total hip or knee arthroplasty: the effect on subsequent transfusion rates.
    Couvret C; Tricoche S; Baud A; Dabo B; Buchet S; Palud M; Fusciardi J
    Anesth Analg; 2002 Apr; 94(4):815-23, table of contents. PubMed ID: 11916778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative treatment with recombinant human erythropoietin or predeposit of autologous blood in women undergoing primary hip replacement.
    Gombotz H; Gries M; Sipurzynski S; Fruhwald S; Rehak P
    Acta Anaesthesiol Scand; 2000 Jul; 44(6):737-42. PubMed ID: 10903019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human erythropoietin in preoperative autologous blood donation did not influence the haemoglobin recovery after surgery.
    Avall A; Hyllner M; Bengtson JP; Carlsson L; Bengtsson A
    Acta Anaesthesiol Scand; 2003 Jul; 47(6):687-92. PubMed ID: 12803585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A restrictive use of both autologous donation and recombinant human erythropoietin is an efficient policy for primary total hip or knee arthroplasty.
    Couvret C; Laffon M; Baud A; Payen V; Burdin P; Fusciardi J
    Anesth Analg; 2004 Jul; 99(1):262-271. PubMed ID: 15281542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of blood management in patients having a total hip or knee arthroplasty.
    Bierbaum BE; Callaghan JJ; Galante JO; Rubash HE; Tooms RE; Welch RB
    J Bone Joint Surg Am; 1999 Jan; 81(1):2-10. PubMed ID: 9973048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin for autologous blood donation in total hip arthroplasty patients.
    Aksoy MC; Tokgozoglu AM
    Arch Orthop Trauma Surg; 2001; 121(3):162-5. PubMed ID: 11262783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of preoperative autologous blood donation in patients having revision hip arthroplasty].
    Sulentić M; Golubić-Cepulić B; Bojanić I; Lukić M; Orlić D; Kolundzić R; Tripković B
    Lijec Vjesn; 2007; 129(6-7):186-90. PubMed ID: 18018708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion options in total joint arthroplasty.
    Keating EM; Ritter MA
    J Arthroplasty; 2002 Jun; 17(4 Suppl 1):125-8. PubMed ID: 12068422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted pre-operative autologous blood donation: a prospective study of two thousand and three hundred and fifty total hip arthroplasties.
    Bou Monsef J; Figgie MP; Mayman D; Boettner F
    Int Orthop; 2014 Aug; 38(8):1591-5. PubMed ID: 24722787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two different dosing regimens of human recombinant erythropoietin beta during preoperative autologous blood donation in patients having hip arthroplasty.
    Buljan M; Nemet D; Golubic-Cepulic B; Bicanic G; Tripkovic B; Delimar D
    Int Orthop; 2012 Apr; 36(4):703-9. PubMed ID: 21964703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood management for patients with hemoglobin level lower than 130 g/l in total knee arthroplasty.
    Minoda Y; Sakawa A; Fukuoka S; Tada K; Takaoka K
    Arch Orthop Trauma Surg; 2004 Jun; 124(5):317-9. PubMed ID: 15060833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who needs autologous blood donation in joint replacement?
    Parvizi J; Chaudhry S; Rasouli MR; Pulido L; Joshi A; Herman JH; Rothman RH
    J Knee Surg; 2011 Mar; 24(1):25-31. PubMed ID: 21618935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood loss and transfusion rates in bilateral total knee arthroplasty.
    Cushner FD; Scott WN; Scuderi G; Hill K; Insall JN
    J Knee Surg; 2005 Apr; 18(2):102-7. PubMed ID: 15915830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative blood management strategies for total knee arthroplasty.
    Kapadia BH; Banerjee S; Issa K; McElroy MJ; Harwin SF; Mont MA
    J Knee Surg; 2013 Dec; 26(6):373-7. PubMed ID: 24122439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.